Clinical Trials
51. A prospective phase II study of induction carboplatin and vinorelbine followed by concomitant topotecan and accelerated radiotherapy (ART) in locally advanced non-small cell lung cancer (NSCLC).
- Author
- Patel SH; Ajlouni M; Chapman R; Lu M; Movsas B; Kim JH;
- Institution
- Department of Radiation Oncology, Henry Ford Hospital, Detroit, Michigan 48202, USA. spatel3@hfhs.org
- Journal
- J Thorac Oncol. 2007 Sep;2(9):831-7.
- Abstract URL
- Click here to view abstract
52. Irinotecan, carboplatin, and imatinib in untreated extensive-stage small-cell lung cancer: a phase II trial of the Minnie Pearl Cancer Research Network.
- Author
- Spigel DR; Hainsworth JD; Simons L; Meng C; Burris HA 3rd; Yardley DA; Grapski R; Schreeder M; Mallidi PV; Greco FA;
- Institution
- Sarah Cannon Research Institute and Tennessee Oncology, PLLC, Nashville, Tennessee 37203, USA.
- Journal
- J Thorac Oncol. 2007 Sep;2(9):854-61.
- Abstract URL
- Click here to view abstract
53. Randomized, placebo-controlled phase II study of vandetanib plus docetaxel in previously treated non small-cell lung cancer.
- Author
- Heymach JV; Johnson BE; Prager D; Csada E; Roubec J; Pesek M; Spasova I; Belani CP; Bodrogi I; Gadgeel S; Kennedy SJ; Hou J; Herbst RS;
- Institution
- Dana-Farber Cancer Institute, Boston, MA, USA.
- Journal
- J Clin Oncol. 2007 Sep 20;25(27):4270-7.
- Abstract URL
- Click here to view abstract
54. Phase II study of efficacy and safety of bevacizumab in combination with chemotherapy or erlotinib compared with chemotherapy alone for treatment of recurrent or refractory non small-cell lung cancer.
- Author
- Herbst RS; O'Neill VJ; Fehrenbacher L; Belani CP; Bonomi PD; Hart L; Melnyk O; Ramies D; Lin M; Sandler A;
- Institution
- The M.D. Anderson Cancer Center, Houston, TX 77030, USA. rherbst@mdanderson.org
- Journal
- J Clin Oncol. 2007 Oct 20;25(30):4743-50. Epub 2007 Oct 1.
- Abstract URL
- Click here to view abstract
55. Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
- Author
- Hirsh V; Soulieres D; Duclos M; Faria S; Del Vecchio P; Ofiara L; Ayoub JP; Charpentier D; Gruber J; Portelance L; Souhami L;
- Institution
- Division of Medical Oncology, Department of Medicine, McGill University Health Center, Montreal, Quebec, Canada. vera.hirsh@muhc.mcgill.ca
- Journal
- J Thorac Oncol. 2007 Oct;2(10):927-32.
- Abstract URL
- Click here to view abstract
56. Regional hyperthermia combined with radiotherapy for locally advanced non-small cell lung cancers: a multi-institutional prospective randomized trial of the International Atomic Energy Agency.
- Author
- Mitsumori M; Zeng ZF; Oliynychenko P; Park JH; Choi IB; Tatsuzaki H; Tanaka Y; Hiraoka M;
- Institution
- Department of Therapeutic Radiology and Oncology, Kyoto University Graduate School of Medicine, 54 Shogoin Kawaharacho, Sakyo-ku, Kyoto, 606-8507, Japan. mitsumo@kuhp.kyoto-u.ac.jp
- Journal
- Int J Clin Oncol. 2007 Jun;12(3):192-8. Epub 2007 Jun 27.
- Abstract URL
- Click here to view abstract
57. Phase II study: integrated palliative care in newly diagnosed advanced non-small-cell lung cancer patients.
- Author
- Temel JS; Jackson VA; Billings JA; Dahlin C; Block SD; Buss MK; Ostler P; Fidias P; Muzikansky A; Greer JA; Pirl WF; Lynch TJ;
- Institution
- Massachusetts General Hospital, Boston, MA 02114, USA. jtemel@partners.org
- Journal
- J Clin Oncol. 2007 Jun 10;25(17):2377-82.
- Abstract URL
- Click here to view abstract
58. A randomized study of involved-field irradiation versus elective nodal irradiation in combination with concurrent chemotherapy for inoperable stage III nonsmall cell lung cancer.
- Author
- Yuan S; Sun X; Li M; Yu J; Ren R; Yu Y; Li J; Liu X; Wang R; Li B; Kong L; Yin Y;
- Institution
- Department of Radiation Oncology, Shandong Cancer Hospital & Institute, Jinan, Shandong Province, China.
- Journal
- Am J Clin Oncol. 2007 Jun;30(3):239-44.
- Abstract URL
- Click here to view abstract
59. Randomized phase II trial of erlotinib or standard chemotherapy in patients with advanced non-small-cell lung cancer and a performance status of 2.
- Author
- Lilenbaum R; Axelrod R; Thomas S; Dowlati A; Seigel L; Albert D; Witt K; Botkin D;
- Institution
- Mount Sinai Cancer Center; 4306 Alton Road; Miami Beach, FL 33140, USA. rlilenbaum@aptiumoncology.com
- Journal
- J Clin Oncol. 2008 Feb 20;26(6):863-9.
- Abstract URL
- Click here to view abstract
60. A triplet chemotherapy with cisplatin, docetaxel and gemcitabine in patients with advanced non-small-cell lung cancer: a phase I/II study.
- Author
- Tabata M; Kozuki T; Ueoka H; Kiura K; Harita S; Tada A; Shibayama T; Takigawa N; Yonei T; Gemba K; Segawa Y; Kishino D; Tada S; Hiraki S; Tanimoto M;
- Institution
- Department of Respiratory Medicine, Okayama University Hospital, Okayama, Japan.
- Journal
- Cancer Chemother Pharmacol. 2007 Jun;60(1):53-9. Epub 2006 Sep 29.
- Abstract URL
- Click here to view abstract
Next: Radiation Therapy
Previous Section
